Inasal

Salbutamol Sulfate, the active ingredient in Inasal, is a bronchodilator (short‑acting β2‑agonist + anticholinergic) presented as an inhalation solution for inhalation use. It treats asthma and chronic obstructive pulmonary disease (COPD) in adults and children as prescribed.

GNH USA supplies Inasal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inasal combines salbutamol and ipratropium to provide bronchodilation in obstructive airway diseases.

- Asthma: rapid relief of bronchospasm and improved airflow. - Chronic obstructive pulmonary disease (COPD): reduction of bronchoconstriction and better symptom control. - Exercise‑induced bronchospasm: prevention of airway narrowing during physical activity.

Adverse reactions may occur with inhalation of the combined bronchodilator.

Common Side Effects: - Tremor: mild muscle shaking, often transient. - Headache: mild to moderate discomfort. - Throat irritation or cough: local irritation from the aerosol. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening airway narrowing. - Angioedema: swelling of face, lips, or throat. - Tachycardia or arrhythmia: rapid or irregular heartbeat. - Severe allergic reaction: rash, itching, or anaphylaxis.

Use Inasal only under medical supervision and consider the following safety measures.

- Cardiac assessment: evaluate for underlying heart disease before use. - Electrolyte monitoring: watch for hypokalemia, especially with diuretics. - Glaucoma caution: avoid in patients with narrow‑angle glaucoma. - Hypersensitivity: discontinue if allergic reactions develop. - Store at room temperature: keep in original container, protect from moisture and light.

Inasal may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Beta‑blockers: may diminish bronchodilator effect. - MAO inhibitors: risk of hypertensive crisis. - Non‑selective beta agonists: additive tachycardia.

Moderate Interactions (Monitor Closely): - Diuretics: increase risk of hypokalemia. - Theophylline: heightened chance of tachyarrhythmia. - Anticholinergic drugs: may exacerbate dry mouth and urinary retention.